Lisa Bright
CDAF

Lisa has over 35 years of experience in the Pharmaceutical and Life Science Industry. She is Chair of Resolution Therapeutics Ltd and a Non-Executive Board Member of several listed and private companies including Dechra Pharmaceuticals PLC, Ascendis Pharma A/S, Immedica Pharma AB. Lisa also advises Syncona Ltd and DRI Capital. In her executive career she was Chief Commercial & Corporate Affairs Officer and President of International for Intercept Pharmaceuticals.

Prior to this, Lisa held various senior roles at Gilead Sciences, Inc and GlaxoSmithKline plc, including Regional General Management, Government Affairs, and sales and marketing. She has particular expertise in HIV, HBV and HCV. Prior to this, Lisa also worked at Sanofi from 1992 to 1996 and GlaxoSmithKline from 1989 to 1992. She received her B.Sc. in Pharmacology from University College London, United Kingdom.
Read More
Dr. Lilian Lou
CDAF

Lily is the President and Program Director of The John C. Martin Foundation, a private nonprofit organization working to bring improved healthcare to socially and economically underserved populations. Prior to the Foundation, she had over 20 years of work experience in the pharmaceutical industry. She directed discovery biology research and clinical studies, and managed regulatory and medical affairs in several pharma and biotech companies focusing on disease areas including viral hepatitis and inflammatory diseases like lupus.

She was also responsible for leading the medical science activities in HIV/AIDS and viral hepatitis especially in resource-challenged countries in Africa, South-Southeast Asia, Eastern Europe and Latin America. Lily earned her PhD in biochemistry from the University of California, Los Angeles, followed by a postdoctoral fellowship at Stanford University.
Read More
Dr. Homie Razavi
CDAF & Nadační fond CDAF

Homie Razavi is the Founder and Managing Director of the Center for Disease Analysis Foundation. He leads epidemiological and decision-analysis initiatives to quantify disease burden, forecast trends, and support national strategy development in more than 100 countries. His team established the Polaris Observatory, the leading global registry for hepatitis epidemiology and treatment data, which informs policy and tracks progress toward WHO elimination targets.

He has over 25 years of experience in decision analysis, with the past 15 years focused on advancing public health strategies for viral hepatitis elimination. His current work emphasizes innovative demonstration projects and sustainable financing models to make hepatitis elimination achievable worldwide. He has authored more than 150 peer-reviewed publications in high-impact journals and holds a PhD in Organic Chemistry and an MBA.
Read More
Dr. Armin Rahimi
CDAF

Armin is a physician with 26 years of experience specializing in Pain Management, practicing in St. Luke's hospital in Chesterfield, Missouri. He earned his medical degree from Kansas City University of Medicine and Biosciences and completed a residency in Anesthesiology and was a chief resident at Baystate Medical Center in Springfield, Massachusetts. He also completed a fellowship training in Pain Management at Washington University in St. Louis, Missouri. Armin is board certified in both Anesthesiology and Pain Management.

Tina Shearer
CDAF & Nadační fond CDAF

Tina is the co-founder and a director of Kaspian, LLC, a real estate holding company.  She is a UCLA trained mindfulness facilitator and is also certified by the International Mindfulness Teachers Association at the professional level. Previously, Tina was a preschool and junior high school teacher, and a preschool director. She holds a certificate from the Monterey Intensive Tutoring in Reading Program and has a BA in Psychology from the University of Colorado, Denver.